home All News open_in_new Full Article
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
today 8 d. ago attach_file Science
attach_file
Other
attach_file
Other
attach_file
Other
attach_file
Politics
attach_file
Technology
attach_file
Economics
attach_file
Economics
attach_file
Sport
attach_file
Economics
attach_file
Other
attach_file
Economics
attach_file
Sport
attach_file
Politics
attach_file
Politics
attach_file
Other
ID: 2292624273